Temido Maria José, Caetano Oliveira Rui, Martins Ricardo, Serôdio Marco, Costa Beatriz, Carvalho César, Santos Eva, Ferreira Luís, Teixeira Paulo, Cipriano Maria Augusta, Tralhão José Guilherme, Alexandrino Henrique
Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra 3000-075, Portugal.
Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal.
Cancer Manag Res. 2020 Nov 17;12:11689-11699. doi: 10.2147/CMAR.S264586. eCollection 2020.
Hepatectomy (Hp) is an alternative approach for the treatment of gastric carcinoma liver metastases (GCLM). However, prognostic factors that may assist patient selection are still controversial. Several pathologic features, such as the growth pattern (GP), associated with prognosis in colorectal cancer liver metastases, were never investigated in GCLM. Our principal aim was to assess if the GP has prognostic impact on GCLM.
Review of the clinical and pathological characteristics of 19 consecutive patients submitted to surgical resection of GCLM with curative intent at our department. Major potential prognostic factors considered were patients' gender, age, timing and extent of Hp, postoperative course, as well as histopathological characteristics of primary and secondary tumors.
Major morbidity occurred in four patients, mortality in one. Median and 5-year overall survival were 17 months and 26.7%, respectively. Ten patients developed recurrent disease and two patients survived more than 10 years. Factors independently associated with overall survival were the absence of major morbidity, distal location of the primary tumor, and desmoplastic GP (p<0.05).
The selection of patients is crucial for the improvement of survival rates of GCLM. Consequently, we demonstrate for the first time that the desmoplastic GP of GCLM is associated with improved outcomes, prompting further research on tumor-host interactions.
肝切除术(Hp)是治疗胃癌肝转移(GCLM)的一种替代方法。然而,有助于患者选择的预后因素仍存在争议。一些病理特征,如生长模式(GP),与结直肠癌肝转移的预后相关,但从未在GCLM中进行过研究。我们的主要目的是评估GP对GCLM是否具有预后影响。
回顾了我们科室19例接受GCLM手术切除且有治愈意向患者的临床和病理特征。所考虑的主要潜在预后因素包括患者的性别、年龄、Hp的时机和范围、术后病程,以及原发肿瘤和继发肿瘤的组织病理学特征。
4例患者发生严重并发症,1例死亡。中位总生存期和5年总生存率分别为17个月和26.7%。10例患者出现复发疾病,2例患者存活超过10年。与总生存期独立相关的因素是无严重并发症、原发肿瘤的远端位置以及促纤维组织增生性GP(p<0.05)。
患者的选择对于提高GCLM的生存率至关重要。因此,我们首次证明GCLM的促纤维组织增生性GP与较好的预后相关,这促使对肿瘤-宿主相互作用进行进一步研究。